The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Mar. 24, 2016
Applicant:

Osiris Therapeutics, Inc., Columbia, MD (US);

Inventors:

Alla Danilkovitch, Columbia, MD (US);

Jinqiang Kuang, Woodstock, MD (US);

Steven Michael Sinclair, Ellicott City, MD (US);

Assignee:

Osiris Therapeutics, Inc., Columbia, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/30 (2006.01); A61L 27/54 (2006.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); A61F 2/38 (2006.01);
U.S. Cl.
CPC ...
A61F 2/30756 (2013.01); A61F 2/3872 (2013.01); A61L 27/3604 (2013.01); A61L 27/3612 (2013.01); A61L 27/3654 (2013.01); A61L 27/3852 (2013.01); A61L 27/54 (2013.01); A61F 2/3094 (2013.01); A61F 2002/30006 (2013.01); A61F 2002/30047 (2013.01); A61F 2002/30807 (2013.01); A61F 2250/00 (2013.01); A61F 2310/00371 (2013.01); A61L 2300/414 (2013.01);
Abstract

Disclosed are compositions comprising a meniscal tissue. For example, disclosed are compositions comprising a meniscal tissue, wherein the meniscal tissue comprises one or more engineered channels. Disclosed are compositions comprising a meniscal tissue comprising viable cells native to the meniscal tissue and devitalized blood vessels. Disclosed are compositions comprising a previously cryopreserved meniscal tissue, wherein after cryopreservation and subsequent thawing the meniscal tissue comprises a) cells native to the meniscal tissue and greater than 30% of the cells are viable, b) extracellular matrix that is native to the meniscal tissue, c) one or more growth factors that are native to the meniscal tissue, and d) depleted amounts of one or more types of functional immunogenic cells. Also disclosed are methods of producing and using these compositions comprising meniscal tissue.


Find Patent Forward Citations

Loading…